https://doi.org/10.4081/mem.2015.30

Il trapianto di utero. Aspetti medici, bioetici e giuridici

Vol. 64 No. 1 (2015)
Published: February 28, 2015
Trial clinico, innovazioni chirurgiche, fattore uterino di infertilità (FUI), trapianto di utero / Clinical trial, surgical innovation, uterine factor infertility (UFI), uterine transplantation
Abstract Views: 817
PDF (Italiano): 10
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Maurizio Faggioni
faggionimp@libero.it
MD ed endocrinologo, Professore Ordinario di Bioetica, Accademia Alfonsiana, Roma, Italy.
Le donne con infertilità da fattore uterino (FUI) dovuto a motivi congeniti (es. sindrome di Rokitansky) o a isterectomia non hanno alcuna possibilità di realizzare il loro desiderio di maternità se non ricorrendo all'adozione o alla maternità surrogata che, però, è proibita in molti paesi. Il trapianto di utero, attualmente in studio, potrebbe rappresentare una alternativa per le donne che desiderano fare esperienza della gravidanza. Dopo decenni di ricerche animali, in Svezia si è avuto la prima nascita dopo trapianto di utero e fecondazione in vitro e questo prova che il trapianto di utero potrebbe essere un trattamento per la FUI. In linea di principio il trapianto è accettabile, ma ci sono molti problemi etici che devono essere considerati nel contesto della sperimentazione e di una eventuale introduzione nella pratica clinica.
----------
Women with uterine factor infertility (UFI) stemming from congenital causes (e.g. Rokitansky syndrome) or from hysterectomy are not able to fulfill their longing for motherhood except resorting to adoption or surrogacy, a practice that is forbidden in many countries. The uterine transplantation is currently under study as an alternative option for women who desire experience pregnancy. After decades of animal researches, in Sweden the first livebirth after uterine transplantation and IVF has been reported and this report is a proof for uterine transplantation as a treatment for UFI. Uterine transplantation is, as principle, morally acceptable, but many ethical issues must be considered in the context of clinical trials and eventually of standard practice.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Faggioni, M. (2015). Il trapianto di utero. Aspetti medici, bioetici e giuridici. Medicina E Morale, 64(1). https://doi.org/10.4081/mem.2015.30

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.

An Open Access Publication is one that meets the following two conditions:

  1. the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
  2. a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.